The R21/Matrix-M vaccine is manufactured by the Serum Institute of India and has already been approved for use in Burkina Faso, Ghana and Nigeria. "As a malaria researcher, I used to dream of the ...
Malaria burden is the highest on the African continent, which accounts for approximately 95% of global malaria cases and 96 ...
The World Health Organization (WHO) is sounding the alarm that malaria is increasing as a threat across the world. "More than ...
Climate change and its impacts, particularly extreme weather and heatwaves, pose a “substantial risk” to progress being made ...
The number of malaria cases rose again in 2022, propelled by flooding and warmer weather in areas once free of the illness.
In a statement, WHO Director-General Tedros Adhanom Ghebreyesus, PhD, said, "The changing climate poses a substantial risk to ...
Health Sector Performance Report for 2022/2023 revealed major causes of deaths, with malaria on top, accounting for 4,245 ...
Children below two years in Cameroon will soon receive shots of Mosquirix, the first-ever Malaria vaccine acquired by the ...
The WHO also gave its stamp of approval to a second malaria vaccine, R21, in October. Total spending on malaria reached $4.1 billion in 2022.
There were more than 249 million malaria cases globally in 2022, which is more than pre-pandemic. | ITV National News ...
Climate change is making the fight against malaria even harder, with the campaign already struggling to make up ground lost ...
GENEVA, Dec 1 (NNN-AGENCIES) - Climate change is making the fight against malaria even harder, with the campaign already struggling to make up ground lost during the Covid-19 pandemic, the World ...
